Abstract There is enough evidence through linkage and substitution mapping to indicate that rat chromosome 1 harbors multiple blood pressure (BP) quantitative trait loci (QTLs). Of these, BP QTL1b was previously reported from our laboratory using congenic strains derived by introgressing normotensive alleles from the LEW rat onto the genetic background of the hypertensive Dahl salt-sensitive (S) rat. The region spanned by QTL1b is quite large (20.92 Mb), thus requiring further mapping with improved resolution so as to facilitate systematic identification of the underlying genetic determinant(s). Using congenic strains containing the LEW rat chromosomal segments on the Dahl salt-sensitive (S) rat background, further iterations of congenic substrains were constructed and characterized. Collective data obtained from this new iteration of congenic substrains provided evidence for further fragmentation of QTL1b with improved resolution. At least two separate genetic determinants of blood pressure underlie QTL1b. These are within 7.40 Mb and 7.31 Mb and are known as the QTL1b1 region and the QTL1b2 region, respectively. A genetic interaction was detected between the two BP QTLs.
Introduction
Genetic analysis of quantitative traits in rodent models is viewed as a suitable alternate approach to facilitate the identification of genetic determinants of complex polygenic traits in humans (Cowley 2006; Deng 2007; Flint and Mott 2001) . Blood pressure (BP) is one such complex polygenic trait. Multiple mapping studies in rat models have provided compelling evidence for the existence of BP quantitative trait loci (QTLs) Joe et al. 2003 ; Lee et al. 2006; Saad et al. 2007a, b) , some of which are located in regions homologous to human chromosomes that are linked to BP (Cowley 2006; Stoll et al. 2000) . While such colocalization of QTLs controlling BP in both rats and humans is intriguing, mapping with improved resolution is required to ultimately reveal the identities of the underlying genetic determinants. The present study is focused on achieving this objective on a previously identified blood pressure QTL (QTL1b) on rat chromosome 1 (Saad et al. 2001) , also documented as ''BP94'' on the Rat Genome Database (http://www.rgd.mcw.edu).
Congenic strains derived by introgressing normotensive alleles from the Lewis rat onto the hypertensive genetic background of the Dahl salt-sensitive (S) rat were used to develop a new iteration of congenic substrains. Data from this new panel of congenic substrains demonstrated that there are at least two genetic determinants of BP within the previously mapped QTL1b. Further dissection of one of these fragmented QTLs, QTL1b1 is prioritized. This QTL region contained five differentially expressed genes as previously reported. This previous study was conducted with the S rat and a congenic strain with a larger introgressed segment, i.e., S.LEW(D1Mco36-D1Rat49) . The status of gene expression of these positional candidates of QTL1b1 as assessed by comparing the gene expression of S with the congenic strain that defines the limits of QTL1b1, i.e., S.LEW(D1Mco36-D1Mco101), is also presented.
Materials and methods

Animals
The inbred Dahl salt-sensitive (SS/Jr or S) rats were from our colony. The Lewis (LEW/NCrlBR) rats, originally obtained from Charles River Laboratories (Wilmington, MA), were maintained in our animal facility and are referred to as LEW. All congenic substrains were constructed as per previously published procedures (Meng et al. 2003) . S.LEW (D1Mco36-D1Rat49) is the progenitor strain for the congenic substrains S.LEW(D1Mco36-D1Rat131a), S.LEW (D1Mco36-D1Rat131b), S.LEW(D1Mco36-D1Mco77), S.LEW (D1Mco36-D1Rat106), S.LEW(D1Mco36-D1Mco101), and S.LEW(D1Mco99-D1Rat49).
Microsatellite markers
New microsatellite markers were developed from sequences identified by (1) comparative mapping of the rat sequence with the Celera mouse genomic sequence (http://www.celera.com) or (2) searching the rat genome sequence data available (RGSC 3.4, December 2004) through the Ensembl database (http://www.ensembl.org). Sequence information of the newly identified polymorphic markers with the prefix D1Mco is available at our website, http://www.hsc.utoledo.edu/depts/physiology/research/rat/ marker.html.
Genotyping
Congenic substrain DNA was extracted from a tail biopsy using the QIAamp Tissue Kit (Qiagen, Chartsworth, CA). PCR-based genotyping with microsatellite markers was done using standard techniques described previously (Gu et al. 1996) .
Phenotyping
Rats were weaned at 30 days of age and maintained on a low-salt (0.3% NaCl) Harlan Teklad diet 7034 (Madison, WI) . In experiments comparing a congenic strain with S rats, 20 or 30 male congenic substrain rats were used. They were matched by age and weight with an equal number of male S control rats, and the animals were caged such that each cage contained a congenic strain and an S rat. In experiments comparing two congenic strains with S rats, the housing of each congenic strain was either with one S rat or with one rat representing the other congenic strain. At 40-42 days of age, the rats were fed a 2% NaCl Harlan Teklad diet, TD94217, for 24 days. Systolic blood pressure was measured using the tail-cuff method on conscious restrained rats warmed to 28°C using semiautomatic equipment from IITC (Woodland Hills, CA). BP was measured once a day for four consecutive days. The BP value of each day was the average of two to three consistent readings. The final BP value used was the average BP value of the 4 days. Rats were euthanized with CO 2 . Final body and heart weights were measured and recorded. Furthermore, in an effort to increase the sample size for testing using the tail-cuff method, the following design was adapted. This method spans 4 days of testing 90 rats for BP by two operators. Day 1: 30 animals of the congenic strain S.LEW(D1Mco36-D1Mco101) were tested with 15 S rats; Day 2: 30 animals of the congenic strain S.LEW(D1Mco36-D1Rat106) were tested with 15 S rats; Day 3 is a repeat of Day1; and Day 4 is a repeat of Day 2. At the end of the study, 10 S rats and 10 S.LEW(D1Mco36-D1Mco101) rats were surgically implanted with C-40 transmitters (Data Sciences International, St. Paul, MN) as described previously (Joe et al. 2003) . After 5 days of recovery, the transmitters were turned on and real-time systolic BP, diastolic BP, mean BP, heart rate, and pulse pressure were monitored and recorded over 4 days. Average BP values of 4 h were used for statistical analysis.
Quantitative real-time PCR Kidney RNA samples from 40-42-day-old S (n = 8) and S.LEW(D1Mco36-D1Mco101) (n = 8) animals that were fed a low -salt (0.3%) diet were collected and analyzed by real-time PCR on an ABI PRISM Ò 7700 Sequence Detection System (Applied Biosystems, Foster City, CA), as described previously . Briefly, total RNA was reversed transcribed using random hexamer primers. The resulting cDNA was diluted and used as template for quantitative PCR using SYBR Green. PCR primers were selected for specificity by NCBI BLAST of the rat genome, and amplicon specificity was verified by first-derivative melting curve analysis using software provided by PerkinElmer/Applied Biosystems. Quantitation and normalization of relative gene expression was accomplished using the comparative C T method or DDC T . DDC T values were converted into ratios by 2 -DDCT and averaged across biological replicates. The expression of the ''housekeeping'' genes malate dehydrogenase (RefSeq accession number NM_012600), glutamate dehydrogenase (NM_012570), and hydroxysteroid sulfotransferase (XM_001081762) was used for normalization as these genes did not exhibit differential expression in our microarray assays. Sequence of primers used for the real-time RT-PCR are given in Supplementary Table 1 .
Statistical analysis
For each congenic substrain tested, the following variables were collected: body weight (g), systolic BP (mmHg), heart weight (mg), and relative heart weight (the ratio of heart weight to final body weight). An independent-samples t test (S vs. a single congenic substrain) or a one-way analysis of variance (ANOVA) with the Tukey post-hoc test of comparisons (S vs. 2 congenic substrains) was done using SPSS software (SPSS, Inc., Chicago, IL). In experiments where a significant difference in body weight between S and a congenic strain was observed, heart weight was corrected for differences in body weight by regression of heart weight on body weight. The corrected heart weight values were used in place of the measured values for those comparisons. Genetic interactions of the BP effects were tested by a two-way ANOVA (2 9 2 ANOVA) using SPSS software. BP effect of each experimental rat in a study was computed by subtracting the mean BP of all the S rats in the study from the BP of the experimental rat. This normalized BP effect was then comparable between experiments and was used for the 2 9 2 ANOVA.
Results
The genetic tools for this study were the panel of S.LEW congenic substrains that are schematically represented in Fig. 1 . These were constructed by screening F 2 populations derived by crossing S with the parental congenic strain. BP QTL1b was previously located within the open bar shown toward the left-hand side of the diagram between the markers D1Rat35 and D1Rat131. To recapitulate, the QTL1b region was inferred as the differential segment between the congenic strain with the BP effect, S.LEW(D1Rat35-D1Rat49), and the congenic strain without the BP effect, S.LEW(D1Mco87-D1Rat71) (Saad et al. 2001) (Fig. 1) . In the present study, this localization was further confirmed by two of the new congenic substrains, S.LEW(D1Mco36-D1Rat131a) and S.LEW(D1Mco36-D1Rat131b), both spanning QTL1b and significantly lowering BP of the S by 17 and 24 mmHg, respectively ( Fig. 1, Table 1 ). Heart weights and relative heart weights of these two congenic strains were also significantly lower than the S, corroborating the BP-lowering effect (Table 1) . Congenic substrains S.LEW(D1Mco36-D1Mco77), S.LEW(D1Mco36-D1Rat106), and S.LEW(D1Mco36-D1Mco101), with shorter introgressed LEW segments from the top end of the QTL, also significantly lowered BP of the S rat by 19, 25, and 25 mmHg (Fig. 1 , Table 1 ). Multiple experiments with these strains indicated that the heart weight data corroborated the observed changes in BP between each congenic strain and S (Table 1) . Together, these data suggest that a BP QTL could be traced within the limits of the congenic substrain with the shortest introgressed segment, S.LEW(D1Mco36-D1Mco101). The region spanned by this QTL, called the QTL1b1 region, is 7,397,670 bp from the marker D1Mco36 to marker D1Mco101. This is a conservative localization because the upper limit of the QTL1b1 region could very well be defined by the proximal end of S.LEW(D1Rat35-D1Rat49) as opposed to the top end of S.LEW(D1Mco36-D1Mco101). However, to arrive at this conclusion, further evidence will be required to demonstrate that the differential top ends of S.LEW(D1Rat35-D1Rat49) and S.LEW(D1Mco36-D1Mco101) (genomic region between D1Mco36 and D1Mco49) do not contain BP QTLs.
Among the congenic substrains shown in Fig. 1 , note that congenic substrain S.LEW(D1Mco85-D1Rat49), which does not contain the QTL1b1 region, also significantly lowers BP of the S rat by 13 mmHg. This suggests that S.LEW(D1Mco85-D1Rat49) contains a genetic determinant of BP, which is clearly not the QTL1b1 region. This second QTL identified within the original QTL1b was labeled the QTL1b2 region (Fig. 1) . Note that a segment of the introgressed LEW alleles within S.LEW(D1Mco85-D1Rat49) was also present within the congenic region of the substrain S.LEW(D1Mco99-D1Rat49), which did not have a significantly lower BP or relative heart weight compared to S (Fig. 1, Table 1 ). This localized the QTL1b2 region to the proximal portion of the congenic region that was not shared between S.LEW(D1Mco85-D1Rat49) and S.LEW(D1Mco99-D1Rat49) (Fig. 1) . This interval spans 7,309,286 bp between the microsatellite markers D1Mco85 and D1Rat106. It is important to note that between the localizations of QTL1b1 and QTL1b2, the localization of QTL1b1 is better because the introgressed region of the congenic strain that ''traps'' QTL1b1 is much Xu et al. 1999a; Xu et al. 1999b . Homology of this region to rat chromosome 1 is represented by the clear segment within the shaded representation of rat chromosome 1 (RNO1). The open bar to the left of the physical map denotes the previously mapped BP QTL1b (Saad et al. 2001) . The physical map of the segment of RNO1 in focus and the location of the microsatellite markers are drawn to scale. Details of the newly identified polymorphic markers with the prefix D1Mco are available at our website (http://www.hsc.utoledo.edu/depts/physiology /research/rat/marker.html). Congenic strains are shown as black bars flanked by white bars. Flanking white bars are regions containing recombinant breakpoints. The crosslined congenic segment toward the distal portion of S.LEW(D1Rat35-D1Rat49) and proximal portion of S.LEW(D1Mco87-D1Rat71) represents heterozygous SL genotype. Underneath each congenic substrain, the BP effect in comparison with S is shown. Values for BP are the mean effect with the SE in parenthesis. Data from S.LEW(D1Mco87-D1Rat71), S.LEW(D1Rat35-D1Rat49), S.LEW(D1Mco36-D1Rat49), and S.LEW(D1Mco85-D1Rat49) are previously published strains (Saad et al. 2001) , the regions of recombination of which are further genotyped using new markers and presented here for completeness. Double arrow pointing downward of S.LEW(D1Mco87-D1Rat71) indicates that the introgressed region shown is incomplete. To the extreme right of the diagram are two double-headed arrows that depict the newly mapped QTL1b1 region and QTL1b2 region shorter than that of the congenic strain that ''traps'' QTL1b2. The region labeled QTL1b2 indicates that it is a prioritized region for further dissection based on cumulative evidence from multiple strains.
Data presented in Fig. 1 show that the LL alleles of QTL1b1 reduced BP by 25 mmHg [represented by the congenic strain S.LEW(D1Mco36-D1Mco101)] and that the LL alleles at QTL1b2 reduced BP by 13 mmHg [represented by S.LEW(D1Mco85-D1Rat49)]. If the two QTLs were additive, then, at least theoretically, in a strain that contains LL alleles at QTL1b1 and QTL1b2 one would expect a BP lowering effect of 25 + 13 = 38 mmHg. However, this is not the case. Note that none of the strains in Fig. 1 show a BP effect of 38 mmHg. Therefore, an interactive effect was suspected. A 2 9 2 ANOVA of the BP effects of the QTL1b1 region and the QTL1b2 region revealed a statistically significant variance in BP that was indeed due to an interaction between the two BP QTLs (p \ 0.01) (Fig. 2) . This interaction resulted in interference between the BP effects of the two QTLs. In other words, the observed net BP effect of LL alleles, when present at both the BP QTLs, was statistically smaller than the expected net BP effect of the two QTLs had they been statistically additive.
Because the QTL1b1 region harbors Nr2f2, which is a prioritized positional candidate for BP QTL1b , we have chosen to focus on the QTL1b1 region for further genetic dissection. Nr2f2 was prioritized as one of the differentially expressed positional candidate genes because a network of perturbations in gene expression was trackable that was related to the potential functionality of Nr2f2 in BP regulation . The observed Values in square brackets are standard error of the mean. Values in parentheses are standard error of the mean difference a Data from these strains were previously published (Saad et al. 2001) and are presented here for completeness b Combined data of two independent experiments c Combined data of three independent experiments. The BP of the S phenotyped along with S.LEW(D1Mco36-D1Rat106) and the BP of the S phenotyped along with S.LEW(D1Mco36-D1Mco101) were not statistically different from each other. Therefore, data analysis was combined for S vs. S.LEW(D1Mco36-D1Rat106) and S.LEW(D1Mco36-D1Mco101) d Effect = Congenic value -S value. A negative number in the Effect column indicates a decrease in a trait in the congenic strain compared to the S rat, whereas a positive number indicates an increase in a trait of the congenic strain compared to the S rat. Number of rats in each group was 20, except for the study comparing S.LEW(D1Mco36-D1Mco101), S.LEW(D1Mco36-D1Rat106), and S rats, in which 30 rats from each group were tested concomitantly. All rats tested were males differential expression of Nr2f2 was identical between lowand high-salt-fed animals. The BP QTL effect of the congenic strain S.LEW(D1Mco36-D1Mco101) encompassing Nr2f2 was also compared with the S by using telemetry (Fig. 3) . The results from telemetry were consistent with those obtained by the tail-cuff method. Systolic BP of S rats (211 ± 2.05 mmHg) was 33 mmHg higher than that of S.LEW(D1Mco36-D1Mco101) (178 ± 1.56 mmHg, p \ 0.0001) (Fig. 3) . Similarly, diastolic BP and pulse pressure of S rats were also significantly higher than that of the congenic strain (15 mmHg, p \ 0.001, and 10 mmHg, p \ 0.001, respectively). The heart rates of S rats, however, were not significantly different from that of the S.LEW(D1Mco36-D1Mco101) (Fig. 3) . Previously, using a custom QTL-interval-specific oligonucleotide array and a whole-genome rat cDNA array, we identified five differentially expressed positional candidates within the newly mapped QTL1b1 region . Interestingly, all of these genes remain differentially expressed between S and the congenic strain that harbors a shorter LEW segment with a BP-lowering effect ( Table 2) . The direction of change in gene expression remained unaltered for three candidate genes, chromodomain helicase DNA binding protein 2 (Chd2) and the novel genes X62953 and XM_980342, but it was opposite for two other candidate genes, i.e., a hypothetical protein (BE108294) and a transcription factor (Nr2f2) ( Table 2 ). The expression of the latter two genes was lower in the congenic strain S.LEW(D1Mco36-D1Mco101) compared with that in the S, whereas it was higher in the congenic strain S.LEW(D1Mco36-D1Rat49) compared with that in the S . This is intriguing and suggests that the direction of change in expression of positional candidate genes such as Nr2f2 should be closely monitored for association with BP in future iterations of mapping. It is also interesting to note that seven out of the nine other transcription factors that are located elsewhere on the genome and known to cross-talk with Nr2f2 remain differentially expressed in the same direction between S and S.LEW(D1Mco36-D1Mco101) (Table 2) as was previously described . Overall, the data suggest that based on the property of differential gene expression of positional candidates, multiple genes remain as candidates for the BP QTL1b1.
Discussion
Considerable attention has been paid to rat chromosome 1 because of the BP QTLs found on this chromosome using several rat models . Multiple-strain comparisons have identified QTLs on this chromosome (Clemitson et al. 2002 (Clemitson et al. , 2007 Cui et al. 2003 Cui et al. , 2004 Frantz et al. 1998 Frantz et al. , 2001 Hubner et al. 1999; Iwai et al. 1998; Joe et al. 2003; Kato et al. 2003; Kloting et al. 1998; Monti et al. 2003; Saad et al. 1999 Saad et al. , 2001 St Lezin et al. 1999; Yagil et al. 2003; Yao et al. 2007) . Of the three RNO1 BP QTLs reported from our laboratory (Saad et al. 2001) , the present study focused on QTL1b. A new iteration of congenic substrains containing shorter introgressed segments spanning QTL1b were constructed and studied for BP effect. Data from two congenic substrains with nonoverlapping congenic regions indicated that the original 20,899,822-bp QTL-containing region contained at least two closely linked but separate genetic determinants. The combined effect of the QTL1b1 region and the QTL1b2 region was nonadditive, that is, the statistical significance of the sum of the effects of the two QTLs is smaller than what would have been expected if the BP effect of the two QTLs were additive. From the point of view of conferring resistance to the development of high BP, such an interaction is unfavorable. This type of interaction is different from two other genetic interactions reported from our laboratory wherein the interaction results in an amplified BP effect: (1) Epistatic effect of BP QTLs on RNO10 and RNO2, wherein the sum effect of protective alleles (against high BP) at the two loci was greater than the effects of each individual QTL (Rapp et al. 1998) and (2) interaction between the two QTLs on RNO5 wherein protective alleles (against high BP) at each locus was not sufficient by itself to demonstrate a BP-lowering effect but required the presence of protective alleles (against high BP) from a closely linked interactive locus (Garrett and Rapp 2002) . In the interest of mapping genetic elements that control BP, understanding that originally identified QTL regions are fragmented arrays of multiple genetic factors that may or may not interact with each other is important. For example, in another recent study from our laboratory, a region as small as 1.35 Mb was found to harbor as many as at least three distinct but opposing genetic elements that control BP (Saad et al. 2007a, b) .
Although it is helpful to know that multiple genetic determinants underlie a BP QTL, this evidence alone is not enough to prioritize candidate gene analysis. One of the common ways to prioritize candidate gene analysis is through the detection of single nucleotide polymorphisms (SNPs) as candidate quantitative trait nucleotides. Of the 19 genes contained within the QTL1b1 region, there is only one coding-region SNP between the SS/Jr and LEW/ Crl strains (http://www.ensembl.org). This variant is located within LOC680906, which is a gene with unknown function. Similarly, of the 81 genes within the QTL1b2 region, there are a total of 7 SNPs within the following genes: Rhesus blood group-associated C glycoprotein, alanyl (membrane) aminopeptidase, protein regulator of cytokinesis 1 (predicted), Unc-45 homolog A, adaptorrelated protein complex 3, beta 2 subunit (predicted), BTB (POZ) domain containing 1, and ADAMTS-like 3 (predicted). None of these genes has been previously implicated in the control of blood pressure and therefore represent novel candidates for BP control.
A number of complementary techniques have been applied to expedite QTL gene identification (Arbilly et al. 2006; Cervino et al. 2007; Cowley 2006; Darvasi 2003; DiPetrillo et al. 2005; Glazier et al. 2002; Liang et al. 2003; Pravenec et al. 2001) . Detection of cisacting expression QTLs (eQTLs) is one way of prioritizing * p \ 0.0001 compared to S. SBP = systolic blood pressure; DBP = diastolic blood pressure; PP = pulse pressure; HR = heart rate; bpm = beats/ min candidate gene analysis (Hubner et al. 2005; Petretto et al. 2006a, b) . This approach has been applied extensively to study the inheritance of gene expression differences in inbred, recombinant-inbred, consomic, and congenic rat strains (Aitman et al. 1999, Cicila and Lee 1998; Hubner et al. 2005; Lee and Cicila 2002; Lee et al. 2003 Lee et al. , 2007 Liang et al. 2002; Malek et al. 2006; Petretto et al. 2006a, b) . Expression QTLs are proposed to represent prototypical targets for a new class of transcription-modulating drugs aimed at treating patients with hypertension and metabolic syndrome (Pravenec and Kurtz 2007) . However, further proof for eQTLs as positional candidates is obtained by retaining such cis-acting eQTLs within progressively shorter introgressed segments of congenic substrains that demonstrate a phenotypic effect, in our case, on BP. The differential expression of candidate genes such as Nr2f2 or BE108294 being in one direction in a congenic strain with a longer introgressed segment and in the opposite direction in a congenic strain with a shorter introgressed segment implies that the expression of these genes is potentially influenced by unknown genetic factors that are closely linked. If the differential expression, regardless of the direction of change, was abolished in the congenic strain with the shorter introgressed segment, then one could conclude that gene expression of Nr2f2 or BE108294 is not the causal element for the observed BP effect elicited by QTL1b1. However, this is not the case. The differential expression of these positional candidate genes remains as a possible contributor to the observed QTL effect of QTL1b1. Conclusive evidence is thus warranted, which can be achieved only by further genetic dissection of this region. Thus, newer iterations of congenic substrains harboring shorter segments flanking Nr2f2 are required to further localize the causative gene(s) and to validate Nr2f2 and/or other differentially expressed positional candidate genes as BP QTLs.
Mapping quantitative trait loci using congenic strains is a time-consuming but time-tested approach to attach physiology to the genome (Jacob and Kwitek 2002; Garrett 2005, 2006; Joe et al. 2003) . The current genetic dissection is certainly an intermediary but obligatory step toward achieving the ultimate goal of identifying the underlying genetic elements that are responsible for the observed alterations in BP. In addition, this information a Gene name abbreviations: Nr2f2, nuclear receptor subfamily 2, group F, member2; Nr4a1, nuclear receptor subfamily 4 group A member 1; Pcbd, 6-pyruvoyl-tetrahydropterin synthase/dimerization cofactor of Tcf1; Rara, retinoic acid receptor alpha; Rxra, retinoic X receptor alpha; Tcf1, transcription factor 1 (hepatic nuclear factor 1); Tcf2, transcription factor 2 (hepatic nuclear factor 2); Zfpm2, zinc finger protein multitype 2. b Accession number correspond to mouse sequence. All other accessions correspond to rat sequences c Numbers in column 3 are the mean ratio values ± SE of 8 independent experiments performed in duplicate may be beneficial to further dissect the human BP QTLs described on the homologous region of QTL1b (Krushkal et al. 1999; Weder et al. 2003; Xu et al. 1999a, b) , i.e., human chromosome 15, which encompass larger genomic segments than the rat BP QTL1b and require further genetic dissection to delineate the number and magnitude of change imparted by the underlying genetic determinants of BP.
